glp-1 and seasonal allergies Do agonists such as Ozempic Monjaro help treat allergies? For general educational purposes only. #ozempic #allergies #doctor Mapping the effectiveness and risks

According to a report from the WHO, in 2022, ~830 million people worldwide had diabetes, and over 95% of diabetes cases are type 2

Many patients starting GLP-1 medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) expect their appetite and food cravings to disappear completely

Be careful about products sold on social media or unofficial websites, and check any product you receive for signs such as spelling mistakes

Mean body weight changes across the groups at the end of 32 weeks were: CagriSema: 15.6% Semaglutide alone: 5.1% Cagrilinitide alone: 8.1% [43] Side effects included nausea (29% of patients), diarrhea (16%) and vomiting (10%) in CagriSema treated patients

The cagrisema comparison with tirzepatide examines a novel semaglutide-cagrilintide combination